02:05 PM EDT, 03/11/2024 (MT Newswires) -- Eagle Pharmaceuticals ( EGRX ) shares fell 6% in recent Monday trading after Brian Cahill resigned as chief financial officer on Friday, effective immediately.

The company said in a regulatory filing that its board has instituted a search for Cahill's successor and named Steven Ratoff as interim CFO. Ratoff remains a member of the board while Cahill will continue as a consultant for a six-month period after his resignation.

The company also said that it decided to terminate the consulting services of Scott Tarriff, former president and chief executive officer, starting Feb. 29.

Price: 5.87, Change: -0.38, Percent Change: -6.08